Injection site reactions occurred in 3.2% and 3.0% of REPATHA-treated and placebo-treated patients, respectively. The most common injection site reactions wereerythema, pain, and bruising. The proportions of patients who discontinued treatment due to local injection site reactions in REPATHA-treated...